@article{JGO17468,
author = {Florencia Neffa and Lucia Garcia and Adriana Della Valle and Florencia Carusso and Carolina Vergara and Daniel Sanchez and Marta Sapone and Noelia Silveyra and Ana Laura Revello and Patricia Esperon},
title = {Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance},
journal = {Journal of Gastrointestinal Oncology},
volume = {9},
number = {3},
year = {2017},
keywords = {},
abstract = {Familial adenomatous polyposis (FAP) is an autosomal dominant genetic condition, caused by mutations in the adenomatous polyposis coli (APC) tumor suppressor gene. Desmoid tumors (DTs) are seen in 15% to 20% of FAP patients. Specific location of mutation serves as a guide to predict colonic and extra colonic manifestations and their aggressiveness. A severe FAP-phenotypic family was registered in a genetic counselling high-risk Uruguayan hereditary cancer clinic. Proband’s DNA was analysed by NGS, detecting a pathogenic mutation in APC gene. All willing family members were counselled and encouraged to be tested. Here we report a kindred formed by 16 individuals with a very severe FAP phenotype. A two-base deletion mutation: c.4393_4394delAG in APC gene and a consequent premature stop codon was detected. DTs were diagnosed in 6 individuals, ranging from 2 to 25 years of age. The causes of death were diverse: gastric cancer, rectal cancer and desmoid tumor. The already described genotype-phenotype correlation has proved its worth in this family, as clinical features reflect the mutation location at 3’ end of APC gene. The inheritable and lethal nature of the disease needs a tailored follow up approach in order to reduce mortality, optimize local tumor control, and preserve patients’ quality of life.},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/17468}
}